Tonix Pharma (TNXP) Announces Issuance of U.S. Patent for Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CR
Go back to Tonix Pharma (TNXP) Announces Issuance of U.S. Patent for Compositions and Uses of Tianeptine Oxalate Salt, the Active Ingredient of TNX-601 CR| TONIX PHARM HLDG (NASDAQ: TNXP) | Delayed: 0.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $7.95 | |||
| Open | $0.16 | 52 Week Low | $0.40 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $-5.33 | |||
| Volume | 990,065 | |||||
